Making The Most Of ACOs: How Biopharma Is Adapting To New Customer Segment
This article was originally published in RPM Report
ACOs have been one of the most hyped innovations in the US health care sector this decade. The buzz may be overdone, but ACOs are now established as a different—and confusing—new customer segment for pharma. How is industry adjusting?